FUJIFILM Diosynth Biotechnologies Billingham Biologics Facility Expansion
Billingham, UK · 2021-Present (ongoing expansion, new facilities opening 2024-2026) · £400m (planned investment package), £100m (microbial fermentation facility)
The judgement call
Account-gated at launchFUJIFILM Diosynth Biotechnologies' £400 million investment in Billingham establishes it as one of the largest multi-modal biopharmaceutical manufacturing sites in the UK. - The expansion significantly boosts the UK's capacity for producing biologics, including vaccines and advanced therapies, which is crucial for national health security and economic growth. - The project highlights the increasing demand for contract development and manufacturing organization (CDMO) services in the biopharmaceutical sector and the importance of advanced manufacturing capabilities.
Key engineering challenges
Scaling up large-scale microbial and cell culture biopharmaceutical manufacturing capacity. - Integrating advanced bioprocessing equipment and technologies into new and existing facilities. - Ensuring compliance with stringent biopharmaceutical Good Manufacturing Practices (GMP) and regulatory requirements. - Developing and optimizing processes for the production of complex biologics, including vaccines and advanced therapies.
Project facts
- Client / owner
- FUJIFILM Diosynth Biotechnologies
- Lead contractor
- —
- Lead designers
- —
- Project type
- expansion | new build
- Scale
- Triples existing microbial production throughput; new production line with 2 x 4000 L bioreactors; new cell culture facility; 110,000 sq ft factory.
- Disciplines
- bioprocess engineering; chemical engineering; mechanical; electrical; civil; structural; cleanroom technology
- Standards & frameworks
- GMP (Good Manufacturing Practices), relevant biopharmaceutical regulations
Sources: FUJIFILM Diosynth Biotechnologies (Sep 2022, https://fujifilmbiotechnologies.fujifilm.com/about/news/fujifilm-diosynth-biotechnologies-breaks-ground-on-large-scale-microbial-manufacturing-facility-expansion-in-billingham-uk/) - Fierce Pharma (Oct 2013, https://www.fiercepharma.com/manufacturing/fujifilm-diosynth-biotechnologies-opens-new-manufacturing-facility) - Bioprocess International (Aug 2024, https://www.bioprocessintl.com/bioprocess-insider/fujifilm-expands-uk-manufacturing-space-with-one-eye-on-the-future) - PharmaSource Global (Aug 2024, https://pharmasource.global/content/news/cdmo-news/fujifilm-diosynth-triples-microbial-capacity-at-100m-billingham-site/) - LinkedIn (Feb 2026, https://www.linkedin.com/posts/stuart-whitehead-19085a111_400-million-uk-manufacturing-investment-activity-7427418989263376384-_JZr)